Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DECO-SSI: Preoperative Decolonization in Orthopedic Surgery
NCT02560155Completed
- Sponsor
- Lindenhofgruppe
- Start
- Nov 2015
- Primary completion
- Oct 2017
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of mupirocin and chlorhexidine in surgical site infection (SSI) (4 arms), sponsored by Lindenhofgruppe. Primary endpoint: Overall number of participants with surgical site infections at 3 months. Started Nov 2015; status: completed.
02
Drugs
mupirocinchlorhexidine
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT02560155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02560155.